NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
2024 · Cancer Immunology Immunotherapy · 23 citations
https://doi.org/10.1007/s00262-024-03795-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
2.3K
Citations
12
h-index
12
i10-index
Judy Mak is an academic researcher from Molecular Oncology (United States). The author has contributed to research in topics: Angiogenesis and VEGF in Cancer & Cancer, Hypoxia, and Metabolism & CAR-T cell therapy research. The author has an h-index of 12, co-authored 23 publications.
Click to start Chat